Oncotelic Therapeutics (OTLC) Short Interest Ratio & Short Volume

Short interest is the volume of Oncotelic Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 18,300 shares of OTLC short. Learn More on Oncotelic Therapeutics' current short interest.

Oncotelic Therapeutics saw a decrease in short interest in October. As of October 31st, there was short interest totaling 18,300 shares, a decrease of 62.1% from the previous total of 48,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Oncotelic Therapeutics: Virios Therapeutics, Inc. (2.44%), vTv Therapeutics Inc. (2.24%), Earth Science Tech, Inc. (0.00%), Protara Therapeutics, Inc. (13.28%), DBV Technologies S.A. (1.41%), Atlantic Coastal Acquisition Corp. II (0.49%), Immix Biopharma, Inc. (2.66%), Provectus Biopharmaceuticals, Inc. (0.02%), Gain Therapeutics, Inc. (2.72%), CalciMedica, Inc. (1.36%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling OTLC is an investing strategy that aims to generate trading profit from Oncotelic Therapeutics as its price is falling. OTLC shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oncotelic Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OTLC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OTLC, twice per month. The most recent reporting period available is October, 31 2024.